• Mashup Score: 0

    Compared to placebo, patients using once-daily oral HU6 100 mg, HU6 300 mg, and HU6 450 mg experienced significant changes in liver fat, volume, and whole-body adiposity after 61 days of treatment.

    Tweet Tweets with this article
    • Patients with #NAFLD and elevated #BMI treated with HU6 experienced significant reductions in liver fat content after 61 days of treatment, with 61% of patients in the pooled #HU6 dose group achieving at least a 30% reduction in liver fat. Learn more: https://t.co/1ZMunBfD2I https://t.co/yXI7KIqW9Q